Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for inhibiting expression of CD274/PD-L1 gene

Compositions and methods for inhibiting expression of CD274/PD-L1 gene

US Patent 9932593 · Granted Apr 3, 2018

Estimated economic value: $160,962,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for the treatment of trinucleotide repeat expansion disorders associated2025
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2025
Oligonucleotides for the treatment of nucleotide repeat expansion disorders asso2025
SERPINA1 iRNA compositions and methods of use thereof2024
Lipid formulated compositions and methods for inhibiting expression of serum amy2024
Complement component C5 iRNA compositions and methods of use thereof2024
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2024
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2023
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2023
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2022
Compositions and methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolat2022
Angiotensinogen (AGT) iRNA compositions and methods of use thereof2022